Stock RDHL REDHILL BIOPHARMA LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Comparison Chart RedHill Biopharma Ltd.

Equities

RDHL

US7574682024

Market Closed - Nasdaq
Other stock markets
 04:30:00 2024-05-31 pm EDT 		5-day change 1st Jan Change
0.4581 USD -0.04% Intraday chart for RedHill Biopharma Ltd. -1.02% -68.62%
May. 06 Redhill Biopharma Awarded China Patent for Investigational Ebola Drug Opaganib MT
May. 06 RedHill Biopharma Ltd. Announces New Opaganib Chinese Patent against Ebola Virus Valid Through 2035 CI
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Compared values

Sector Change 5d. change 1st Jan change 1-year change 5-years change Capi. ST MT LT
REDHILL BIOPHARMA LTD.
Biopharmaceuticals
-0.04%-1.02%-68.62%-79.18%-99.85% 14.6M
Bullish
Bearish
Neutral

Technical Rankings Surperformance

  1. Stock Market
  2. Equities
  3. RDHL Stock
  4. Charts RedHill Biopharma Ltd.
  5. Comparison Chart